{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:10:26Z","timestamp":1790291426054,"version":"4.1.0"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,11,1]]},"DOI":"10.1093\/intimm\/dxh327","type":"journal-article","created":{"date-parts":[[2005,9,27]],"date-time":"2005-09-27T00:14:09Z","timestamp":1127780049000},"page":"1495-1503","source":"Crossref","is-referenced-by-count":4,"title":["Partial rescue of B cells in microphthalmic osteopetrotic marrow by loss of response to type I IFNs"],"prefix":"10.1093","volume":"17","author":[{"given":"Kirstin M.","family":"Roundy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Spangrude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janis J.","family":"Weis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Weis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,9,26]]},"reference":[{"key":"key\n\t\t\t\t20171010203630_BIB1","doi-asserted-by":"crossref","unstructured":"Hodgkinson, C. A., Moore, K. J., Nakayama, A. et al.1993. Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein. Cell74:395.","DOI":"10.1016\/0092-8674(93)90429-T"},{"key":"key\n\t\t\t\t20171010203630_BIB2","doi-asserted-by":"crossref","unstructured":"Mansky, K. C., Marfatia, K., Purdom, G. H., Luchin, A., Hume, D. A. and Ostrowski, M. C. 2002. The microphthalmia transcription factor (MITF) contains two N-terminal domains required for transactivation of osteoclast target promoters and rescue of mi mutant osteoclasts. J. Leukoc. Biol.71:295.","DOI":"10.1189\/jlb.71.2.295"},{"key":"key\n\t\t\t\t20171010203630_BIB3","doi-asserted-by":"crossref","unstructured":"Hemesath, T. J., Steingrimsson, E., McGill, G. et al.1994. Microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family. Genes Dev.8:2770.","DOI":"10.1101\/gad.8.22.2770"},{"key":"key\n\t\t\t\t20171010203630_BIB4","doi-asserted-by":"crossref","unstructured":"Moore, K. J. 1995. Insight into the microphthalmia gene. Trends Genet.11:442.","DOI":"10.1016\/S0168-9525(00)89143-X"},{"key":"key\n\t\t\t\t20171010203630_BIB5","doi-asserted-by":"crossref","unstructured":"Roundy, K., Kollhoff, A., Eichwald, E. J., Weis, J. J. and Weis, J. H. 1999. Microphthalmic mice display a B cell deficiency similar to that seen for mast and NK cells. J Immunol.163:6671.","DOI":"10.4049\/jimmunol.163.12.6671"},{"key":"key\n\t\t\t\t20171010203630_BIB6","doi-asserted-by":"crossref","unstructured":"Tagaya, H., Kunisada, T., Yamazaki, H. et al.2000. Intramedullary and extramedullary B lymphopoiesis in osteopetrotic mice. Blood95:3363.","DOI":"10.1182\/blood.V95.11.3363.011k29_3363_3370"},{"key":"key\n\t\t\t\t20171010203630_BIB7","doi-asserted-by":"crossref","unstructured":"Roundy, K., Smith, R., Weis, J. J. and Weis, J. H. 2003. Overexpression of RANKL implicates IFN-beta-mediated elimination of B-cell precursors in the osteopetrotic bone of microphthalmic mice. J. Bone Miner. Res.18:278.","DOI":"10.1359\/jbmr.2003.18.2.278"},{"key":"key\n\t\t\t\t20171010203630_BIB8","doi-asserted-by":"crossref","unstructured":"Theill, L. E., Boyle, W. J. and Penninger, J. M. 2002. RANK-L and RANK: T cells, bone loss, and mammalian evolution. Annu. Rev. Immunol.20:795.","DOI":"10.1146\/annurev.immunol.20.100301.064753"},{"key":"key\n\t\t\t\t20171010203630_BIB9","doi-asserted-by":"crossref","unstructured":"Lange, U., Saitou, M., Western, P., Barton, S. and Surani, M. 2003. The Fragilis interferon-inducible gene family of transmembrane proteins is associated with germ cell specification in mice. BMC Dev. Biol.3:1.","DOI":"10.1186\/1471-213X-3-1"},{"key":"key\n\t\t\t\t20171010203630_BIB10","doi-asserted-by":"crossref","unstructured":"Dutt, P., Wang, J. F. and Groopman, J. E. 1998. Stromal cell-derived factor-1 alpha and stem cell factor\/kit ligand share signaling pathways in hemopoietic progenitors: a potential mechanism for cooperative induction of chemotaxis. J. Immunol.161:3652.","DOI":"10.4049\/jimmunol.161.7.3652"},{"key":"key\n\t\t\t\t20171010203630_BIB11","doi-asserted-by":"crossref","unstructured":"Ma, Q., Jones, D. and Springer, T. A. 1999. The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment. Immunity10:463.","DOI":"10.1016\/S1074-7613(00)80046-1"},{"key":"key\n\t\t\t\t20171010203630_BIB12","doi-asserted-by":"crossref","unstructured":"Ansel, K. M., Ngo, V. N., Hyman, P. L. et al.2000. A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature406:309.","DOI":"10.1038\/35018581"},{"key":"key\n\t\t\t\t20171010203630_BIB13","doi-asserted-by":"crossref","unstructured":"Legler, D. F., Loetscher, M., Roos, R. S., Clark-Lewis, I., Baggiolini, M. and Moser, B. 1998. B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1\/CXCR5. J. Exp. Med.187:655.","DOI":"10.1084\/jem.187.4.655"},{"key":"key\n\t\t\t\t20171010203630_BIB14","doi-asserted-by":"crossref","unstructured":"Anderson, D. M., Maraskovsky, E., Billingsley, W. L. et al.1997. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature390:175","DOI":"10.1038\/36593"},{"key":"key\n\t\t\t\t20171010203630_BIB15","doi-asserted-by":"crossref","unstructured":"Wong, B. R., Josien, R., Lee, S. Y. et al.1997. TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J. Exp. Med.186:2075.","DOI":"10.1084\/jem.186.12.2075"},{"key":"key\n\t\t\t\t20171010203630_BIB16","doi-asserted-by":"crossref","unstructured":"Lacey, D. L., Timms, E., Tan, H. L. et al.1998. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell93:165.","DOI":"10.1016\/S0092-8674(00)81569-X"},{"key":"key\n\t\t\t\t20171010203630_BIB17","doi-asserted-by":"crossref","unstructured":"Yasuda, H., Shima, N., Nakagawa, N. et al.1998. Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL. Proc. Natl Acad. Sci. USA95:3597.","DOI":"10.1073\/pnas.95.7.3597"},{"key":"key\n\t\t\t\t20171010203630_BIB18","doi-asserted-by":"crossref","unstructured":"Nakagawa, N., Kinosaki, M., Yamaguchi, K. et al.1998. RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis. Biochem. Biophys. Res. Commun.253:395.","DOI":"10.1006\/bbrc.1998.9788"},{"key":"key\n\t\t\t\t20171010203630_BIB19","doi-asserted-by":"crossref","unstructured":"Hsu, H., Lacey, D. L., Dunstan, C. R. et al.1999. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc. Natl Acad. Sci. USA96:3540.","DOI":"10.1073\/pnas.96.7.3540"},{"key":"key\n\t\t\t\t20171010203630_BIB20","doi-asserted-by":"crossref","unstructured":"Takayanagi, H., Kim, S., Matsuo, K. et al.2002. RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta. Nature416:744.","DOI":"10.1038\/416744a"},{"key":"key\n\t\t\t\t20171010203630_BIB21","doi-asserted-by":"crossref","unstructured":"Biron, C. A. 2001. Interferons alpha and beta as immune regulators\u2014a new look. Immunity14:661.","DOI":"10.1016\/S1074-7613(01)00154-6"},{"key":"key\n\t\t\t\t20171010203630_BIB22","doi-asserted-by":"crossref","unstructured":"Wang, J., Lin, Q., Langston, H. and Cooper, M. D. 1995. Resident bone marrow macrophages produce type 1 interferons that can selectively inhibit interleukin-7-driven growth of B lineage cells. Immunity3:475.","DOI":"10.1016\/1074-7613(95)90176-0"},{"key":"key\n\t\t\t\t20171010203630_BIB23","doi-asserted-by":"crossref","unstructured":"Lin, Q., Dong, C. and Cooper, M. D. 1998. Impairment of T and B cell development by treatment with a type I interferon. J. Exp. Med.187:79.","DOI":"10.1084\/jem.187.1.79"},{"key":"key\n\t\t\t\t20171010203630_BIB24","doi-asserted-by":"crossref","unstructured":"Muller, U., Steinhoff, U., Reis, L. F. et al.1994. Functional role of type I and type II interferons in antiviral defense. Science264:1918.","DOI":"10.1126\/science.8009221"},{"key":"key\n\t\t\t\t20171010203630_BIB25","doi-asserted-by":"crossref","unstructured":"Tan, S. S. and Weis, J. H. 1992. Development of a sensitive reverse transcriptase PCR assay, RT-RPCR, utilizing rapid cycle times. Genome Res.2:137.","DOI":"10.1101\/gr.2.2.137"},{"key":"key\n\t\t\t\t20171010203630_BIB26","doi-asserted-by":"crossref","unstructured":"Zabel, M. D., Weis, J. J. and Weis, J. H. 1999. Lymphoid transcription of the murine CD21 gene is positively regulated by histone acetylation. J. Immunol.163:2697.","DOI":"10.4049\/jimmunol.163.5.2697"},{"key":"key\n\t\t\t\t20171010203630_BIB27","doi-asserted-by":"crossref","unstructured":"Takayanagi, H., Kim, S. and Taniguchi, T. 2002. Signaling crosstalk between RANKL and interferons in osteoclast differentiation. Arthritis Res.4(Suppl. 3):S227.","DOI":"10.1186\/ar581"},{"key":"key\n\t\t\t\t20171010203630_BIB28","doi-asserted-by":"crossref","unstructured":"Vasconcellos, R., Braun, D., Coutinho, A. and Demengeot, J. 1999. Type I IFN sets the stringency of B cell repertoire selection in the bone marrow. Int. Immunol.11:279.","DOI":"10.1093\/intimm\/11.2.279"},{"key":"key\n\t\t\t\t20171010203630_BIB29","doi-asserted-by":"crossref","unstructured":"Gongora, R., Stephan, R. P., Zhang, Z. and Cooper, M. D. 2001. An essential role for Daxx in the inhibition of B lymphopoiesis by type I interferons. Immunity14:727.","DOI":"10.1016\/S1074-7613(01)00152-2"},{"key":"key\n\t\t\t\t20171010203630_BIB30","doi-asserted-by":"crossref","unstructured":"Aoki, K., Shimoda, K., Oritani, K. et al.2003. Limitin, an interferon-like cytokine, transduces inhibitory signals on B-cell growth through activation of Tyk2, but not Stat1, followed by induction and nuclear translocation of Daxx. Exp. Hematol.31:1317.","DOI":"10.1016\/j.exphem.2003.08.011"},{"key":"key\n\t\t\t\t20171010203630_BIB31","doi-asserted-by":"crossref","unstructured":"Oritani, K., Medina, K. L., Tomiyama, Y. et al.2000. Limitin: an interferon-like cytokine that preferentially influences B-lymphocyte precursors. Nat. Med.6:659.","DOI":"10.1038\/76233"},{"key":"key\n\t\t\t\t20171010203630_BIB32","doi-asserted-by":"crossref","unstructured":"Kouro, T., Medina, K. L., Oritani, K. and Kincade, P. W. 2001. Characteristics of early murine B-lymphocyte precursors and their direct sensitivity to negative regulators. Blood97:2708.","DOI":"10.1182\/blood.V97.9.2708"},{"key":"key\n\t\t\t\t20171010203630_BIB33","doi-asserted-by":"crossref","unstructured":"Hwang, S. Y., Hertzog, P. J., Holland, K. A. et al.1995. A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responses. Proc. Natl Acad. Sci. USA92:11284.","DOI":"10.1073\/pnas.92.24.11284"},{"key":"key\n\t\t\t\t20171010203630_BIB34","doi-asserted-by":"crossref","unstructured":"Simonet, W. S., Lacey, D. L., Dunstan, C. R. et al.1997. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell89:309.","DOI":"10.1016\/S0092-8674(00)80209-3"},{"key":"key\n\t\t\t\t20171010203630_BIB35","doi-asserted-by":"crossref","unstructured":"Tsuda, E., Goto, M., Mochizuki, S. et al.1997. Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochem. Biophys. Res. Commun.234:137.","DOI":"10.1006\/bbrc.1997.6603"},{"key":"key\n\t\t\t\t20171010203630_BIB36","doi-asserted-by":"crossref","unstructured":"Yasuda, H., Shima, N., Nakagawa, N. et al.1998. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG\/OCIF inhibits osteoclastogenesis in vitro.Endocrinology139:1329.","DOI":"10.1210\/endo.139.3.5837"},{"key":"key\n\t\t\t\t20171010203630_BIB37","doi-asserted-by":"crossref","unstructured":"Bosio, E., Cluning, C. L. and Beilharz, M. W. 2001. Low-dose orally administered type I interferon reduces splenic B cell numbers in mice. J. Interferon Cytokine Res.21:721.","DOI":"10.1089\/107999001753124453"}],"container-title":["International Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/intimm\/article-pdf\/17\/11\/1495\/2432792\/dxh327.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T19:32:39Z","timestamp":1683228759000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/intimm\/article\/17\/11\/1495\/813357\/Partial-rescue-of-B-cells-in-microphthalmic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9,26]]},"references-count":37,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2005,9,26]]},"published-print":{"date-parts":[[2005,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/intimm\/dxh327","relation":{},"ISSN":["1460-2377","0953-8178"],"issn-type":[{"value":"1460-2377","type":"electronic"},{"value":"0953-8178","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,11]]},"published":{"date-parts":[[2005,9,26]]}}}